(2S,5S,14S,17R,20S,23S,29S,32S)-32-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-2-(2-(2-aminophenyl)-2-oxoethyl)-23-(3-aminopropyl)-14,20-bis(carboxymethyl)-5-((S)-1-carboxypropan-2-yl)-29-((R)-1-hydroxyethyl)-8-(hydroxymethyl)-17-methyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatetratriacontane-1,34-dioic Acid
Product Name |
(2S,5S,14S,17R,20S,23S,29S,32S)-32-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-2-(2-(2-aminophenyl)-2-oxoethyl)-23-(3-aminopropyl)-14,20-bis(carboxymethyl)-5-((S)-1-carboxypropan-2-yl)-29-((R)-1-hydroxyethyl)-8-(hydroxymethyl)-17-methyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatetratriacontane-1,34-dioic Acid
|
Product Code |
DA-D029-35
|
Chemical name |
(2S,5S,14S,17R,20S,23S,29S,32S)-32-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-2-(2-(2-aminophenyl)-2-oxoethyl)-23-(3-aminopropyl)-14,20-bis(carboxymethyl)-5-((S)-1-carboxypropan-2-yl)-29-((R)-1-hydroxyethyl)-8-(hydroxymethyl)-17-methyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatetratriacontane-1,34-dioic Acid
|
Synonyms |
17-Methyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatetratriacontane-1,34-dioic Acid, (2S,5S,14S,17R,20S,23S,29S,32S)-32-((R)-4-amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-2-(2-(2-aminophenyl)-2-oxoethyl)-23-(3-aminopropyl)-14,20-bis(carboxymethyl)-5-((S)-1-carboxypropan-2-yl)-29-((R)-1-hydroxyethyl)-8-(hydroxymethyl)-;
|
Impurity |
NA
|
CAS Number |
NA
|
Alternate CAS # |
NA
|
Molecular form |
C72H103N17O27
|
Appearance |
NA
|
Melting Point |
NA
|
Mol. Weight |
1638.69
|
Storage |
2-8°C Refrigerator
|
Solubility |
NA
|
Stability |
NA
|
Category |
chiral standards,heterocycles,pharmaceutical standards,intermediates,fine chemicals
|
Boiling Point |
NA
|
Applications |
NA
|
Dangerous Goods Info |
NA
|
References |
NA
|
Extra Notes |
NA
|
Documents (MSDS) |
No Data Available
|
Keywords |
NA |